Market Overview
AI-enhanced LIMS platforms combine traditional sample tracking, workflow management, and data storage with machine learning algorithms for predictive analytics, anomaly detection, and intelligent decision support. The global AI-in-LIMS market reached approximately USD 350 million in 2025 and is estimated at USD 407 million in 2026, growing to approximately USD 864 million by 2031 at a 16.25% compound annual growth rate, representing a specialized and rapidly expanding subset of the broader laboratory informatics market.
Growth Drivers
The primary catalyst for AI-in-LIMS adoption is the exponential increase in laboratory data generated by genomics, proteomics, and high-throughput screening in drug discovery and clinical diagnostics. Laboratories across pharmaceutical, biotech, and research sectors are deploying AI to automate routine workflows, reduce human error, and accelerate time-to-insight from experimental results. Additionally, tightening regulatory requirements around data integrity, audit trails, and compliance reporting are pushing laboratories to adopt intelligent systems capable of maintaining continuous compliance with minimal manual intervention.
Segmentation and Regional Analysis
The AI-in-LIMS market can be segmented by deployment model, component, application vertical, and geography, with cloud-based deployments gaining traction over traditional on-premise solutions due to lower capital requirements and enhanced collaboration capabilities. Key application segments include pharmaceutical and biotechnology companies, clinical diagnostics laboratories, contract research organizations, and academic and government research institutions.
Trends and Outlook
What are the recent trends and outlook?
The AI-in-LIMS market is expected to sustain its rapid growth trajectory as laboratories prioritize data-driven decision-making, operational efficiency, and regulatory compliance through intelligent automation. Generative AI and large language models are beginning to be integrated into LIMS platforms for automated report generation, natural language querying of laboratory data, and predictive maintenance scheduling for laboratory equipment. The convergence of LIMS with electronic lab notebooks, laboratory execution systems, and enterprise data platforms is creating more unified digital laboratory ecosystems.
Key Companies and Developments
Named companies and quantified developments shaping the Ai In Laboratory Information Management Systems Lims Market market.
- •Sapio Sciences - Sapio Sciences integrated Anthropic's Claude Cowork into the Sapio Platform in April 2026, which gave scientists one conversational interface to query, analyze, and act on LIMS and ELN data with traceability and user attribution.
- •Illumina - Illumina launched Connected Multiomics v1.1 in February 2026 with AI-guided workflow suggestions learned from expert-created pipelines, which reduced the need for deep bioinformatics knowledge when designing integrated analyses.
- •Ultima Genomics - Sapio Sciences and Ultima Genomics formed a partnership in September 2025 to combine ultra-high-throughput sequencing with AI-driven LIMS workflows, which reflects growing demand for scalable and traceable multi-omics execution.
- •PRECISE-SG100K program - Singapore's PRECISE-SG100K program also reported nearly 50,000 whole-genome sequences through a LIMS-mediated cloud pipeline, with AI-driven quality control helping reduce turnaround time by more than 3-fold after workflow optimization.
- •Pharmaceutical testing laboratories - Pharmaceutical testing laboratories accounted for nearly 34% of total LIMS deployments, followed by biotechnology laboratories at 26%.
- •Biotechnology laboratories - Biotechnology laboratories represented nearly 31% of U.S. installations, followed by pharmaceutical manufacturing laboratories at 36%.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2026 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.